Maat Pharma (XPAR:MAAT) Price-to-Operating-Cash-Flow : (As of Jun. 03, 2025)

View and export this data going back to 2021. Start your Free Trial

What is Maat Pharma Price-to-Operating-Cash-Flow?

As of today (2025-06-03), Maat Pharma's share price is €5.64. Maat Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €-1.71. Hence, Maat Pharma's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Maat Pharma's Price-to-Operating-Cash-Flow or its related term are showing as below:

XPAR:MAAT's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 24.275
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Maat Pharma's Cash Flow from Operations per share for the six months ended in Dec. 2024 was €-0.68. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €-1.71.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 19.80% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -25.10% per year.

During the past 7 years, Maat Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 19.80% per year. The lowest was -100.20% per year. And the median was -36.50% per year.

Maat Pharma Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Maat Pharma's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Maat Pharma Price-to-Operating-Cash-Flow Chart

Maat Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

Maat Pharma Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Maat Pharma's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Maat Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Maat Pharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Maat Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Maat Pharma's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Maat Pharma Price-to-Operating-Cash-Flow Calculation

Maat Pharma's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	5.64	/	-1.711
	=

Maat Pharma's Share Price of today is €5.64.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Maat Pharma's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2024 was €-1.71.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

Maat Pharma Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Maat Pharma's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Maat Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Maat Pharma SA (XPAR:MAAT) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

4RD:Germany

Address

70 Avenue Tony Garnier, Lyon, FRA, 69007

Website

https://www.maatpharma.com

Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Maat Pharma Headlines

No Headlines